FIS
NAMS icon

FCPM III Services’s NewAmsterdam Pharma NAMS Stock Holding History

FCPM III Services’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$294M Hold
9,198,900
– – 40.77% 1
2025
Q4 		$323M Sell
9,198,900
-13,484
-0.1% -$491K 42.3% 1
2025
Q3 		$262M Sell
9,212,384
-1,419,729
-13% -$34M 52.36% 1
2025
Q2 		$193M Sell
10,632,113
-303,197
-3% -$5.53M 52.16% 1
2025
Q1 		$224M Buy
10,935,310
+338,129
+3% +$7.52M 54.11% 1
2024
Q4 		$272M Sell
10,597,181
-1,234,280
-10% -$26.2M 45.98% 1
2024
Q3 		$196M Hold
11,831,461
– – 33.73% 2
2024
Q2 		$227M Hold
11,831,461
– – 33.52% 2
2024
Q1 		$280M Hold
11,831,461
– – 39.56% 1
2023
Q4 		$132M Buy
+11,831,461
New +$108M 38.94% 1

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
DFO
Duquesne Family Office New York $2.94B AUM 61.92% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return